....3) Does the 34.4 million shares of Zenith Epigenetics Ltd represent a 1 for 3 reverse split? 4) If so, is this reverse split for the purpose of increasing the value of individual shares of Zenith Epigenetics Ltd to meet Nasdaq listing requirements?....

Bear, unfortunately I wouldn't call it a reverse split. There are currently have about 103 million valued at about $1.00 US. A reverse split (1:3) would take us to about 34 million shares at $3.00. Unfortuntately, it looks like 34 million shares at $1.00. So it wouldn't help us or the Nasdaq requirements (you knew all that already!).